This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.


Description:

The goals of the Association for Molecular Pathology Pharmacogenomics (PGx) Working Group of the Association for Molecular Pathology Clinical Practice Committee are to define the key attributes of PGx alleles recommended for clinical testing and a minimum set of variants that should be included in clinical PGx genotyping assays. The CYP2C9 project and manuscript provides recommendations for a minimum panel of variant alleles (Tier 1) and an extended panel of variant alleles (Tier 2) that will aid clinical laboratories when designing assays for CYP2C9 testing.


Practice Guideline Available Here

Speaker: Stuart A. Scott, PhD, FACMG

Moderator: Yuan Ji, PhD, FACMG

Duration: 1 hr

Level of Instruction: Basic


Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:
CME/CMLE 1.0

Purchase Webinar + CME/CMLE

(Just $5.00 USD for AMP members)

SAM 1.0

Purchase Webinar + SAM

(Just $10.00 USD for AMP members)

Continuing Education Credit must be purchased and claimed by March 20, 2020

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

 

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Course Information
Course Date:
September 05, 2019
Course Objectives
  • To identify sequence variants that define CYP2C9 star (*) allele haplotypes.
  • To describe the AMP PGx Working Group and examine the reported CYP2C9 'Tier 1 and 2' recommended alleles.
  • To review CYP2C9 pharmacogenetics and highlight clinically relevant medications that are metabolized by CYP2C9.
Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists
Individual topic purchase: Selected
Products
Streaming
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $195.00